Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO

Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept

(2011) T. D. van DIJKEN et al.   JOURNAL OF RHEUMATOLOGY

Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment

(2010) Vinodh Kakkassery et al.   CURRENT EYE RESEARCH

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients

(2010) T. R. Southwood et al.   RHEUMATOLOGY

Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis

(2010) V. Papsdorf et al.   RHEUMATOLOGY

Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis

(2010) IL Östile et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

(2009) H. M. Albers et al.   ARTHRITIS AND RHEUMATISM

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

(2009) E. H. Giannini et al.   ARTHRITIS AND RHEUMATISM

Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis

(2009) A. MAGNANI et al.   JOURNAL OF RHEUMATOLOGY

Pattern of Disease Onset, Diagnostic Delay, and Clinical Features in Juvenile Onset and Adult Onset Ankylosing Spondylitis

(2009) S. OZGOCMEN et al.   JOURNAL OF RHEUMATOLOGY

Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations

(2009) S. Ringold et al.   RHEUMATOLOGY

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

(2009) D. Fouache et al.   RHEUMATOLOGY

Crohn’s disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature

(2009) V. Wiegering et al.   RHEUMATOLOGY INTERNATIONAL

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis

(2008) P Tynjala et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis

(2008) Silvia Magni-Manzoni et al.   ARTHRITIS AND RHEUMATISM

Assessing current outcomes of juvenile idiopathic arthritis: A cross-sectional study in a tertiary center sample

(2008) Nicoletta Solari et al.   ARTHRITIS AND RHEUMATISM

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM